Resistance to HSP90 inhibition involving loss of MCL1 addiction-Reference-Cited by-同舟云学术

Resistance to HSP90 inhibition involving loss of MCL1 addiction

Published:2015-06-22 Issue:12 Volume:35 Page:1483-1492
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Busacca S,Law E W P,Powley I R,Proia D A,Sequeira M,Le Quesne J,Klabatsa A,Edwards J M,Matchett K B,Luo J L,Pringle J H,El-Tanani M,MacFarlane M,Fennell D A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2015213.pdf

Reference51 articles.

1. Trepel J, Mollapour M, Giaccone G, Neckers L . Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 2010; 10: 537–549.

2. Workman P, Al-Lazikani B . Drugging cancer genomes. Nat Rev Drug Discov 2013; 12: 889–890.

3. Workman P, Al-Lazikani B, Clarke PA . Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology. Curr Opin Pharmacol 2013; 13: 486–496.

4. Moulick K, Ahn JH, Zong H, Rodina A, Cerchietti L, Gomes DaGama EM et al. Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nat Chem Biol 2011; 7: 818–826.

5. Rutherford SL, Lindquist S . Hsp90 as a capacitor for morphological evolution. Nature 1998; 396: 336–342.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity;Journal for ImmunoTherapy of Cancer;2023-12

2. HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia;Current Issues in Molecular Biology;2023-08-23

3. Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma;Nature Communications;2023-05-20

4. STAT5A modulates gastric cancer progression via upregulation of CD44;Genomics;2023-05

5. Functional precision oncology using patient-derived assays: bridging genotype and phenotype;Nature Reviews Clinical Oncology;2023-03-13